Michael A. Beeuwsaert

Alerion Biomedical, Inc. manufactures novel technologies for improving detection. It also manufactures biomarkers and contrast media for preclinical and clinical imaging devices. The company is headquartered in San Diego, CA.

Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million.

Numira, Inc. develops and provides molecular imaging technologies for scientific discovery and drug development. Its products include AltaBlu Prime, AltaNexus and AltaViewer. The firm operates as a contract research organization, which provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models. The company services include 3D oncology cell screening, histology, image analysis and imaging. Its therapeutic areas such as CNS, bone, pulmonary, oncology, and inflammation provide extensive value for many researchers. Through the combination of novel software technologies and imaging capabilities, Numira provides clients with an unmatched array of pre-clinical services for research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other therapeutic areas. Numira was founded in 2005 by Michael A. Beeuwsaert and Charles Keller and is headquartered in Salt Lake, UT.